Human medicines European public assessment report (EPAR): Beyfortus, nirsevimab, Date of authorisation: 31/10/2022, Revision: 15, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 24 April 2026 - 13:38

Human medicines European public assessment report (EPAR): Beyfortus, nirsevimab, Date of authorisation: 31/10/2022, Revision: 15, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/beyfortus

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters